Insmed to Host Investor and Analyst Event on May 8, 2023

— The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More—

BRIDGEWATER, N.J., April 24, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will host an investor and analyst event on Monday, May 8, 2023. The event, titled "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More," will take place from 8:00 a.m. to 12:00 p.m. ET in New York and will be simultaneously webcast. 

Read more at prnewswire.com